As an early adopter of artificial intelligence for healthcare applications, Claritev is taking a proactive approach to ensuring we use this technology responsibly. In this article, members of our Responsible Data Use Committee share key considerations to help clients evaluate AI solutions with an eye to its responsible use.
MultiPlan reported its first quarter 2024 results, highlighting $234.5 million in revenue and $5.7 billion in identified medical cost savings. The company also outlined progress on its transformation strategy despite industry disruptions affecting claims volume.
Claritev is aware of the articles recently published by the New York Times and fundamentally disagrees with the depiction of our position in the industry and the services that we provide. Read our full statement here >
MultiPlan reported fourth quarter and full year 2023 results, including $244.1 million in Q4 revenue and $961.5 million for the full year. The company highlighted progress on its growth strategy, cost savings initiatives and improved financial position heading into 2024.
In the property and casualty world, out-of-network medical bills represent a large portion of all new bills — over 50% in some states. So, property and casualty payors must take care in choosing an out-of-network solution. In this post, we list our top five considerations when choosing an out-of-network solution for your workers’ compensation or auto medical bills.
MultiPlan announced that members of its management team will participate in several upcoming financial conferences, engaging with investors to discuss current industry trends and company performance. The events will include presentations and investor meetings, with select sessions available via webcast through the company’s investor relations website. [claritev.com]
A high-level overview of the proposed Federal IDR Operations rules under the No Surprises Act, highlighting key changes aimed at improving communication, reducing disputes, and streamlining payment determinations between payers and providers.
Leveraging data science, Claritev is working to build intelligent processes into each of its solutions. Claritev's Negotiation Services was the first to benefit from a data science project with the implementation of the Negotiation Prioritization Tool.
November 8, 2023 – MultiPlan Corporation (NYSE: MPLN)… announced that its Board of Directors has extended its current $100 million program to repurchase shares of the Company’s Class A common stock through December 31, 2024. To date, the Company has repurchased $13.1 million… leaving up to $86.9 million in authorized repurchases… This extension demonstrates our continued confidence in the strength of MultiPlan’s business and cash flow.
MultiPlan reported third quarter 2023 results, including $242.8 million in revenue and $5.8 billion in identified medical cost savings. The company highlighted continued progress on its growth plan, including new product launches and ongoing efforts to strengthen its capital structure.